The day after the election, some celebrated Trump's win and RFK Jr.'s potential role as a public health decision-maker. Why? They finally felt seen.

The Ulman Foundation, a longstanding staple in the community, recently held a ribbon-cutting for its new brick "Legacy ...

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.